Summary
Increased use of glucose through glycolysis is characteristic for neoplastic growth while the significance of serum-free fatty acids for regulation of energy metabolism in cancer is poorly understood. We studied whether serum-free fatty acids (FFA) interfere with glycolytic metabolism of lymphoproliferative neoplasms as assessed with 2-F18-fluoro-2-deoxy-D-glucose ([F18]FDG) and positron emission tomography (PET). Twelve patients with newly diagnosed non-Hodgkin’s lymphoma (n = 9) or Hodgkin’s disease (n = 3) participated in this study before start of oncologic treatment. Each patient underwent two [F18]FDG PET studies within 1 week after overnight fast: once during high fasting serum FFA concentrations and once after reduction of serum FFA by administration of acipimox. Acipimox is a nicotinic acid derivative that inhibits lipolysis in peripheral tissues and induces a striking reduction in circulating FFA concentration. In all cases, dynamic PET imaging over the tumour area was performed for 60 min after injection of [F18]FDG. Both graphical analysis (rMRFDG) and single scan approach (SUV) were used to compare tumour uptake of [F18]FDG under high fasting FFA concentrations and after pharmacologically decreased FFA concentrations. Serum FFA concentrations were reduced significantly from 0.92 ± 0.42 mmol l–1 at baseline to 0.26 ± 0.31 mmol l–1 after acipimox administration (P = 0.0003). Plasma glucose, serum insulin and lactate concentrations were similar during both approaches. The retention of glucose analogue [F18]FDG in tumour was similar between baseline and acipimox studies. Median rMRFDG of a total of 12 involved lymph nodes in 12 patients was 21.9 μmol 100 g–1 min–1 (range 8.7–82.5) at baseline and 20.1 μmol 100 g–1 min–1 (range 10.7–81.7) after acipimox. The respective values for median SUV were 7.8 (range 3.6–18.6) and 6.0 (range 4.1–20.2). As expected, [F18]FDG uptake in myocardium was clearly enhanced by acipimox due to reduction of circulating FFAs. In conclusion, blood fatty acids appear to have minor significance for [F18]FDG uptake in lymphoma. This suggests that glucose utilization is uncoupled of FFA metabolism and indicates that glucose-free fatty acid cycle does not operate in lymphomatous tissue. Glucose appears to be the preferred substrate for energy metabolism in tumours, in spite of the high supply of FFAs in the fasting state. Although acipimox and other anti-lipolytic drugs have potential for treatment of catabolic state induced by cancer, they are not likely to interfere with tumour energy metabolism which is fuelled by glucose.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Carbone, P. P., Kaplan, H. S., Musshoff, K., Smithers, D. W. & Tubiana, M. (1971). Report of the Committee on Hodgkin’s Disease Staging Classification. Cancer Res 31: 1860–1861.
Cederbaum, A. I. & Rubin, E. (1976). Fatty acid oxidation, substrate shuttles, and activity of the citric acid cycle in hepatocellular carcinomas of varying differentation. Cancer Res 36: 2980–2987.
Conti, P. S., Lilien, D. L., Hawley, K., Keppler, J., Grafton, S. T. & Bading, J. R. (1996). PET and [18F]-FDG in oncology: a clinical update. Nucl Med Biol 23: 717–735.
Gullino, P. M., Grantham, F. H. & Courtney, A. H. (1967). Glucose consumption by transplanted tumors in vivo. Cancer Res 27: 1031–1040.
Hamacher, K., Coenen, H. H. & Stöcklin, G. (1986). Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27: 235–238.
Kadish, A. H., Little, R. L. & Strenberg, J. C. (1968). A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14: 116–131.
Kern, K. A. & Norton, J. A. (1988). Cancer cachexia. J Parent Enteral Nutr 12: 286–298.
Knuuti, M. J., Nuutila, P., Ruotsalainen, U., Saraste, M., Härkönen, R., Ahonen, A., Hartiala, J., Teräs, M., Haaparanta, M., Wegelius, U., Haapanen, A. & Voipio-Pulkki, L-M (1992). Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med 33: 1255–1262.
Knuuti, M. J., Mäki, M., Yki-Järvinen, H., Voipio-Pulkki, L. M., Härkönen, R., Haaparanta, M. & Nuutila, P. (1995). The effect of insulin and FFA on myocardial glucose uptake. J Mol Cell Cardiol 27: 1359–1367.
Kuzuya, H., Blix, B. M., Horwitz, D. L., Steiner, D. F. & Rubenstein, A. (1977). Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26: 22–29.
Lapela, M., Leskinen, S., Minn, H., Lidholm, P., Klemi, P., Söderström, K-O, Bergman, J., Haaparanta, M., Ruotsalainen, U., Solin, O. & Joensuu, H. (1995). Increased glucose metabolism in untreated non-Hodgkin’s lumphoma: A study with positron emission tomography and fluorine-18-fluorodeoxyglucose. Blood 9: 3522–3527.
Laverazzi, M., Milanesi, E., Oggioni, E. & Pamparana, F. (1989). Results of a phase IV study carried out with acipimox in type II diabetic patients with concomitant hyperlipidemia. J Int Med Res 17: 373–380.
Lehninger, A. L. (1975). Organ interrelationships in the metabolism of mammals. In Biochemistry, pp. 829–852. Worth: New York
Marbach, E. & Weil, M. (1967). Rapid enzymatic measurement of blood lactate and pyruvate. Clin Chem 13: 314–325.
Miles, J., Glasscock, R., Aikens, J., Gerich, J. & Haymond, M. (1983). A microfluorometric method for determination of free fatty acids in plasma. J Lipid Res 24: 96–99.
Minn, H., Nuutila, P., Lindholm, P., Ruotsalainen, U., Bergman, J., Teräs, M. & Knuuti, J. (1994). In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma. Cancer 73: 1490–1498.
Minn, H., Zasadny, K. R., Quint, L. E. & Wahl, R. L. (1995). Lung cancer: reproducibility of quantitative measurements for evaluating 2-(F-18)-fluoro-2-deoxy-D-glucose uptake in PET. Radiology 196: 167–173.
Mulligan, H. D., Beck, S. A. & Tislade, M. J. (1992). Lipid metabolism in cancer cachexia. Br J Cancer 66: 57–61.
Nariai, T., DeGeorge, J. J., Greig, N. H., Genka, S., Rapoport, S. I. & Pyrdon, A. D. (1994). Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intacerebrally implanted tumor and brain in awake rats. Clin Exp Metastasis 12: 213–225.
Neely, J. R. & Morgan, H. E. (1974). Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36: 413–459.
Nogushi, M., Rose, D. P., Earashi, M. & Miayazaki, I. (1995). The role of fatty acids and eicosanoid synthesis inhibitors in breast carcinoma. Oncology 52: 265–271.
Norton, J. A., Burt, M. E. & Brennan, M. F. (1980). In vivo utilization of substrate by human sarcoma-bearing limbs. Cancer 45: 2934–2939.
Nuutila, P., Koivisto, V. A., Knuuti, J., Ruotsalainen, U., Teräs, M., Haaparanta, M., Bergman, J., Solin, O., Voipio-Pulkki, L-M, Wegelius, U. & Yki-Järvinen, H. (1992). Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 89: 1767–1774.
Nuutila, P., Knuuti, M. J., Raitakari, M., Ruotsalainen, U., Teräs, M., Voipio-Pulkki, L. M., Haaparanta, M., Solin, O., Wegelius, U. & Yki-Järvinen, H. (1994). Effect of antilipolysis on heart and skeletal muscle glucose uptake in overnight fasted humans. Am J Physiol 267: E941–946.
Obeid, O. A. & Emery, P. W. (1997). Effect of acute acipimox administration on the rates of lipid and glygogen synthesis in cachectic tumor-bearing rats. Nutr Cancer 28(1): 100–106.
Olefsky, J. M. (1991). Obesity. In Harrison’s Principles of Internal Medicine, Vol 1, Wilson JD, Barunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK (eds), p. 411. McGrawHill: New York
Patlak, C. S. & Balsberg, R. G. (1985). Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 5: 584–590.
Paul, R. (1987). Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med 28: 288
Phelps, M. E., Huang, S. C., Hoffman, E. J., Selin, C., Sokoloff, L. & Kuhl, D. E. (1979). Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol 6: 371
Randle, P. J., Garland, P. B., Hales, C. N. & Newsholme, E. A. (1963). The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785–789.
Randle, P. J., Newsholme, E. A. & Garland, P. B. (1964). Regulation of glucose uptake by muscle. Effects of fatty acids, ketone bodies and pyruvate, and alloxan, diabetes and starvation, on the uptake and metabolism fate of glucose in rat heart and diaphragm muscles. Biochem J 93: 652–665.
Ratib, O., Phelps, M. E., Huang, S-C, Henze, E., Selin, C. E. & Schelbert, H. R. (1982). Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucleic Med 23: 577–586.
Shipp, M. A. & Harrington, D. P. (1993). Chairpersons in the international non-Hodgkin’s lymphoma prognostic factors project: a predictive model for aggressive lymphoma. N Engl J Med 329: 987
Spence, A. M., Muzi, M., Graham, M. M., O’Sullivan, F., Krohn, K. A., Link, J. M., Lewellen, T. K., Lewellen, B., Freeman, S., Berger, M. & Ojemann, G. A. (1998). Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. J Nucl Med 39: 440–448.
Spinks, T. J., Jones, T., Gilardi, M. C. & Heather, J. D. (1988). Physical performance of the latest generation of commercial positron scanners. IEEE Trans Nucl Sci 35: 721–725.
Stansfeld, A. G., Diebold, J., Noel, H., Kapanci, Y., Rilke, F., Kelenyi, G., Sundström, C., Lennert, K., van Unnik, J. A. M., Mioduszewska, O. & Wright, D. M. (1988). Updated Kiel classification for lymphomas. Lancet 1: 292–293.
Tayek, J. A. (1992). A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr 11: 445–456.
The Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982). National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: summary and description of working formulation for clinical usage. Cancer 49: 2112
Thiebaund, D., DeFronzo, R. A., Jacot, E., Golay, A., Acheson, K., Maeder, E., Jequir, E. & Felber, J. B. (1982). Effect of long-chain triglyceride infusion on glucose metabolism in man. Metab Clin Exp 31: 1128–1136.
Toomey, D., Redmond, P. & Bouchier-Hayes, D. (1995). Mechanisms mediating cancer cachexia. Cancer 76: 2418–2426.
Wahl, R. L., Zasadny, K., Helvie, M., Hutschins, G. D., Weber, B. & Cody, R. (1993). Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol 11: 2101–2111.
Warburg, O. (1930). The Metabolism of Tumours. Constable: London
Weber, G. (1977). Enzymology of cancer cells (Part II). N Engl J Med 296: 541–551.
Woodard, H. O., Bigler, R. E. & Freed, B. (1975). Expression of tissue isotope distribution. J Nucl Med 16: 958–959.
Zasadny, K. & Wahl, R. L. (1993). Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 189: 847–850.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Nuutinen, J., Minn, H., Bergman, J. et al. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. Br J Cancer 80, 513–518 (1999). https://doi.org/10.1038/sj.bjc.6690386
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690386
Keywords
This article is cited by
-
Myo-Myo: Yes, papa. Eating sugar? No, papa!
European Journal of Nuclear Medicine and Molecular Imaging (2011)